Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Including medical news, pharmaceutical industry news, new drug approvals, applications and clinical trial results.
Daily MedNews
-- Here are the latest clinical trials, courtesy of CenterWatch:
Heartburn
Volunteers are being sought to take part in a clinical trial of an investigational drug. Candidates who meet study criteria will be medically supervised.
The research site is...
Here are some of the latest health and medical news developments, compiled by editors of HealthDay:
Vaccine Said to Ward Off Bird Flu
An experimental bird flu vaccine appears to generate an immune response in people that can help guard against...
WEDNESDAY, Aug. 27 -- A chemical produced in the brain may play a role in regulating appetite and the likelihood of becoming obese, according to a new study.
For the study, researchers looked at a group of 33 people who had WAGR syndrome, a genetic...
WEDNESDAY, Aug. 27 -- Magnesium sulfate, given to mothers at risk of preterm delivery, cut the rate of cerebral palsy in their babies by nearly half, a new study found.
"If deemed to be at high or immediate risk of delivery prior to 32 weeks, women...
WEDNESDAY, Aug. 27 -- Fat cells in obese people are "sick" compared to those in lean people, a new study shows.
Published in the September issue of Diabetes, a group of researchers from the Temple University School of Medicine analyzed fat samples...
Pharma Industry News
NICE Final Guidance Recommends Lucentis As Cost-Effective Treatment for Wet AMD, a Leading Cause of Blindness
Lucentis is only approved therapy to demonstrate improvement in vision and vision-related function in vast majority of wet AMD...
- Clinical data showing unprecedented 89% reduction in risk of GIST relapse with use of Gleevec after surgery are basis for FDA, EMEA, Swissmedic filings
EAST HANOVER, N.J., August 27, 2008 /PRNewswire/ -- Novartis announced today that Gleevec(R)...
SAN DIEGO and INDIANAPOLIS, August 26, 2008 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. and Eli Lilly and Company in a conference call today provided context and additional information regarding the August 18, 2008 U.S. Food and Drug...
Information for Healthcare Professionals Natalizumab Injection for Intraveneous Use (marketed as Tysabri)
ROCKVILLE, Md., Aug. 25, 2008--FDA ALERT [8/2008]: The FDA has recently received information from the manufacturer about two new cases of...
Diabetes sites gain popularity as treatment options change
NEW YORK, August 25, 2008 /PRNewswire/ -- Diabetes treatment brand sites from Januvia, Actos, Byetta, and Avandia are among the top pharmaceutical product websites in terms of primary care...
New Drug Approvals
WOODCLIFF LAKE, N.J., August 23, 2008 /PRNewswire/ -- Eisai Corporation of North America and its partner Helsinn Healthcare SA today announced that the U.S. Food and Drug Administration (FDA) has approved a new oral formulation of Aloxi...
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Aug 22, 2008 - Amgen Inc. (NASDAQ: AMGN) today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Nplate (romiplostim), the first and only platelet producer for the...
SUMMIT, N.J.--(BUSINESS WIRE)--Aug 21, 2008 - Celgene Corporation today announced Vidaza (azacitidine) received expanded U.S. Food and Drug Administration (FDA) approval to reflect new overall survival achieved in the AZA-001 survival study of...
WASHINGTON, August 15, 2008 /PRNewswire/ -- Prestwick Pharmaceuticals, Inc., a privately-held pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Xenazine (tetrabenazine) for the treatment of chorea...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Aug 11, 2008 - Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Viread (tenofovir disoproxil fumarate) for the treatment of chronic...
New Drug Applications
TITUSVILLE, N.J., August 26, 2008 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced today that the Food and Drug Administration (FDA) has asked for additional data before it will approve the company's...
VANCOUVER and DEERFIELD, IL, August 11, 2008 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. and its co-development partner Astellas Pharma US, Inc. ("Astellas") today announced that they have received an action letter dated August 8, 2008 from the...
BRIDGEWATER, N.J., August 08, 2008 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that U.S. Food and Drug Administration (FDA) has assigned priority review status for its New Drug Application (NDA) for Multaq (dronedarone). The priority...
HORSHAM, Pa., August 08, 2008 /PRNewswire/ -- Centocor, Inc., today announced that the U.S. Food and Drug Administration (FDA) has extended the review timeline for the Biologic License Application for ustekinumab, a subcutaneous biologic therapy, by...
EXTON, Pa.--(BUSINESS WIRE)--Jul 30, 2008 - Othera Pharmaceuticals, Inc., announced today the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for OT-730, an oculoselective beta-blocker, as a...
Clinical Trials
Studies demonstrate efficacy and safety of VisonacTM and the potential for a simplified Photodynamic Therapy (PDT) procedure for treatment of moderate to severe acne
Oslo, Norway, August 27, 2008 – Photocure announces positive preliminary results...
Study led by Hollings Cancer Center researcher finds risk greatest in ages 25-44
CHARLESTON, S.C., Aug. 26 /PRNewswire/ -- Individuals with a history of nonmelanoma skin cancer (NMSC), especially those who had it at a younger age, are at...
STANFORD, Calif.--(BUSINESS WIRE)--Aug 26, 2008 - Scientists at the Stanford University School of Medicine are shedding light on how type-1 diabetes begins.
Doctors have known the disease is caused by an autoimmune attack on the pancreas, but the...
PARSIPPANY, N.J.--(BUSINESS WIRE)--Aug. 26, 2008 - The Medicines Company (NASDAQ: MDCO) today announced that the results of VELOCITY, a pivotal Phase 3 safety and efficacy trial of its new intravenous (IV) therapy Cleviprex(TM) (clevidipine...
Pramipexole Clinical Trial Programme in Restless Legs Syndrome (RLS) Reveals New Significant Results
Studies from pramipexole clinical programme confirm efficacy in treating highly prevalent RLS-associated symptoms, including limb pain and mood disturbance
Ingelheim, Germany, 26 August 2008 – Results from a large pramipexole trial programme in...
More News Resources
Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals
